Yield10 Bioscience Inc reports results for the quarter ended in September - Earnings Summary

Yield10 Bioscience

14/11/2022 22:52

* Yield10 Bioscience Inc  YTEN.OQ  reported a quarterly
adjusted
loss of 71 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 65 cents per share.
    * Revenue rose 20.7% to $111.00 thousand from a year ago;
analysts
expected $133.00 thousand. 
    * Yield10 Bioscience Inc's reported EPS for the quarter was
a loss
of 71 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Yield10 Bioscience Inc shares had fallen by 9.0% this
quarter and lost 44.7% so far this year.
    * The company reported a quarterly loss of $3.49 million.
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $9.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:52 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.65          -0.71          Missed
 Jun. 30 2022      -0.69          -0.70          Missed
 Mar. 31 2022      -0.65          -0.68          Missed
 Dec. 31 2021      -0.63          -0.61          Beat